Keywords: cortex, enzon, mylan, results, among, firms, still

Cortex, Enzon And Mylan Results

Article | 11 September 1997

Print This

Among US firms still reporting results for the period to June 30, 1997,Cortex Pharmaceuticals saw a net loss of $4.9 million ($0.83 per ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in